Serous borderline ovarian tumors (SBOTs) are slowgrowing, non-invasive ovarian epithelial neoplasms. SBOTs are considered to be distinct entities that give rise to invasive low-grade serous carcinomas (LGCs), which have a relatively poor prognosis and are unrelated to high-grade serous carcinomas (HGCs). The mechanisms underlying the progression of non-invasive SBOTs to invasive epithelial ovarian carcinomas are not understood. We recently established short-term cultures of SBOT cells from tumor biopsies and showed that inactivation of p53, retinoblastoma (Rb) and/or PP2A by the simian virus 40 (SV40) large (LT) and small T antigens extends the life span of the cells and endows them with the ability to invade Matrigel-coated transwells. In this study, we show that concurrent inhibition of p53 and Rb by the SV40 LT produces cells (referred to as SBOT4-LT) with increased life span and cell invasion. To distinguish the roles of p53 and Rb in the progression from SBOTs to invasive ovarian carcinomas, we performed small interfering RNA-mediated knockdown of endogenous p53 in a spontaneously immortalized SBOT cell line, SBOT3.1, which increased cell invasion. This increased invasive activity was associated with the transcriptional downregulation of E-cadherin, correlated with an increase in PIK3CA levels and the increased activation of Akt. Conversely, in invasive LGC-derived MPSC1 cells, enhancing the levels of p53 decreased cell invasion and diminished the phosphatidylinositol 3-kinase (PI3K)/Akt-mediated downregulation of E-cadherin. Inhibition of Rb also enhanced invasiveness, but did not affect the levels of PIK3CA and E-cadherin in SBOT3.1 cells, suggesting that it functions by a different pathway. To our knowledge, this study is the first to show that p53 has an important role in the progression from SBOTs to invasive carcinomas. In addition, our findings suggest that downregulation of E-cadherin by the PI3K/Akt pathway contributes to this progression.
Introduction
Serous borderline ovarian tumors (SBOTs) are the most common type of ovarian borderline tumors, and are neither clearly benign nor obviously malignant. The recurrence of SBOT is often delayed, and when they do occur, the tumors typically show morphological features of SBOTs or invasive low-grade serous carcinomas (LGCs), which are associated with a significantly poorer prognosis (Gershenson et al., 1998) . Unlike benign tumors, SBOTs show histological features of malignancy, including nuclear atypia, cellular stratification, mitotic activity and stromal microinvasion, but they lack the destructive stromal invasion seen in invasive high-grade serous carcinomas (HGCs) (Parker et al., 2004 ). An increasing number of studies support a model in which epithelial ovarian cancer progression is divided into two pathways. This model proposes that type I tumors tend to be invasive LGCs that arise from noninvasive SBOTs, whereas type II tumors are invasive HGC, which grow rapidly and without a definitive precursor lesion . Genetic studies have shown that KRAS and BRAF are frequently mutated in SBOTs and LGCs, but are rarely mutated in HGCs, whereas p53 is usually normal in SBOTs and LGCs but is frequently mutated in HGCs (Ho et al., 2004; Singer et al., 2005) .
Recently, a microarray study showed that SBOTs do not exhibit any abnormalities in genes involving cellular proliferation, metastasis and chromosomal instability, which are associated with invasive HGC. Rather, when compared with normal ovarian surface epithelium, SBOTs are characterized by overexpressed p53 and changes in genes associated with the p53 pathway. In addition, analysis of the gene expression profiles of invasive LGC shows that they lack the increased p53 expression and signaling activity observed in SBOT (Bonome et al., 2005) . These observations suggest that the overexpression of p53 in SBOT has an important role in the distinct phenotype associated with this lesion, and that the return of p53 to levels expressed in ovarian surface epithelium is related to the progression of these non-invasive tumors to the more aggressive invasive LGC.
We recently established an in vitro culture system with human SBOT cells. Cultured SBOT cells resembled LGC in their levels of CA125 secretion, telomerase activation and E-cadherin expression. They secreted matrix metalloproteinases, but, in contrast to ovarian cancer cells, cultured SBOT cells grew slowly, were essentially non-invasive and exhibited limited motility, which are characteristics that resemble their behavior in vivo. Multicolor fluorescent in situ hybridization and microarray comparative genomic hybridization analyses showed that the genes involved in p53 regulation and phosphatidylinositol 3-kinase (PI3K) signaling were amplified . Most importantly, inactivation of p53, retinoblastoma (Rb) and PP2A by the simian virus 40 (SV40) large (LT) and small T antigens allowed the cells to acquire characteristics associated with neoplastic progression, including increased cell motility and invasion, and epithelialmesenchymal transition (EMT) . Thus, transformation of SBOT cells to a more aggressive phenotype seems to be mediated in part by changes in the activity of p53, Rb and/or PP2A.
PI3K signaling has been shown to have an important role in several aspects of tumor progression, including cell migration, invasion and proliferation (Roymans and Slegers, 2001 ). Gain and/or amplification of the PIK3CA gene, which encodes the catalytic subunit of PI3K (p110a), and its increased expression are associated with enhanced PI3K activity in ovarian cancer cells (Shayesteh et al., 1999) . In addition, Akt, which is a major downstream target of PI3K, is amplified or activated in human tumors, including ovarian cancer (Sun et al., 2001) . In many types of human cancers, it has been shown that more than 80% of the mutations in PIK3CA gene are located at hotspots within two small conserved regions, the helical domain (encoded by exon 9) and the kinase domain (encoded by exon 20) (Samuels et al., 2004) . In ovarian cancer, a mutation analysis study shows that compared with endometrioid and clear cell ovarian carcinomas, serous carcinomas harbor less PIK3CA mutation, whereas the PIK3CA is rarely mutated in the borderline tumor (Campbell et al., 2004) . Recently, it was shown that p53 directly binds to and transcriptionally inhibits a PIK3CA promoter (Astanehe et al., 2008) . These results suggest that inactivation of p53 and subsequent upregulation of PIK3CA contribute to the progression of ovarian cancer.
E-cadherin is a membrane glycoprotein located at cell adherens junctions. Loss of E-cadherin expression, which is a hallmark of EMT, is mainly due to the upregulation of Snail, Slug, Twist, ZEB1 and other transcription factors, which repress E-cadherin (Cano et al., 2000; Bolos et al., 2003; Yang et al., 2004; Huber et al., 2005) . Ovarian cancer cells with low E-cadherin expression are more invasive, and clinicopathological studies have shown that lack of E-cadherin is a predictor of poor clinical survival (Veatch et al., 1994; Darai et al., 1997) . Recently, activation of the PI3K/Akt axis has emerged as a central feature of EMT. Squamous cell carcinoma cell lines exhibit constitutive activation of Akt, which downregulates the expression of E-cadherin and promotes tumorigenicity and invasiveness (Grille et al., 2003) . Such findings indicate that activation of the PI3K/Akt axis coupled with the downregulation of E-cadherin expression may be important in promoting tumorigenesis.
In this study, we first discriminated between the effects of p53 and Rb on the invasive ability of SBOT cells by individually inhibiting the corresponding genes. We found that inhibition of p53, Rb or both in combination allows SBOT cells to acquire a more aggressive phenotype. In addition, we show that inhibition of p53 alone is sufficient to increase the cell invasion of SBOT cells and to downregulate the expression of E-cadherin, an effect that is mediated by increased p110a expression and Akt activation. In contrast, enhancing the expression of p53 in invasive LGC-derived MPSC1 cells decreased cell invasion and diminished p110a expression and Akt activation. These results suggest that p53 regulates the transition of SBOT cells from non-invasive to invasive ovarian carcinomas by activating the PI3K/Akt pathway and decreasing the expression of E-cadherin.
Results
Inhibition of p53 and Rb leads to morphological epithelial-mesenchymal transition (EMT) and increases SBOT cell invasion As shown in Figure 1a , SBOT4 cells exhibited a whorled and irregular epithelial growth pattern, which is characteristic of this cell type. In contrast, SBOT4 cells infected with SV40 LT exhibited a more atypical and scattered morphology, indicating that EMT also occurs in the absence of small T antigens. Immunostaining showed that all the SBOT4-LT cells were LT positive and continued to express keratin, confirming their epithelial origin (Supplementary Figure 1) . SBOT4 cells were essentially non-invasive, whereas SBOT4-LT cells were invasive at a level similar to the highly invasive ovarian cancer cell line SKOV3 (Figure 1b ). SV40 LT inhibits p53 and Rb. To further discriminate between the effects of p53 and Rb on cell invasion, we knocked down endogenous p53, Rb or both genes. To make this experiment technically feasible, we used the spontaneously immortalized line, SBOT3.1, instead of SBOT4 cells because the latter have a limited life span. To confirm that this spontaneous immortalization did not affect the pathways examined in this study, the levels of target molecules were compared between SBOT3.1 and SBOT3.3 cells. These two cell lines are derived from the same patient, but SBOT3.3 is not spontaneously immortalized. Western blot analysis showed that the protein expression levels of the target molecules examined in this study did not differ significantly between SBOT3.1 and SBOT3.3 cells. In addition, their invasive ability was similar (Supplementary Figure 2) . Moreover, the RNA sequence results showed that p53 is wild type in SBOT3.1 cells (data not shown).
The invasion assay showed that SBOT3.1 cells were non-invasive, whereas knockdown of p53 or Rb alone significantly increased cell invasion. However, knockdown of both p53 and Rb did not have any synergistic effects on cell invasion (Figure 1c ). To further determine whether p53 is critical for the regulation of progression from non-invasive SBOT to invasive low-grade serous carcinomas (LGC), loss-and gain-of-function approaches were used to compare SBOT3.1 with MPSC1 cells, which were established from a LGC. As shown in Figure 1d , MPSC1 cells were highly invasive, and overexpression of p53 significantly decreased their invasive ability. In addition, small interfering RNA (siRNA)-mediated knockdown of p53 or Rb or overexpression of p53, did not significantly affect cell proliferation in SBOT3.1 and MPSC1 cells (Supplementary Figures 3a and b) . Moreover, overexpression of p53 did not increase apoptosis in MPSC1 cells (Supplementary Figure 3c ). These results suggest that overexpressed p53 represses cell invasion in SBOT and MPSC1 cells.
Inhibition of p53, but not Rb, increases p110a expression and Akt activation To examine whether PIK3CA is wild type or mutated in the SBOT cells, we sequenced the two hotspot-containing exons (9 and 20) in SBOT3.1 cells. The sequence results showed that no mutations were detected in exon 9 or 20 in SBOT3.1 cells, which confirmed that the PIK3CA mutation is rarely in borderline tumors (data not shown). To determine whether the PI3K/Akt pathway contributes to the inhibition of p53-induced cell invasion, we analyzed the levels of PIK3CA in SBOT3.1 and MPSC1 cells. As shown in Figure 2a , knockdown of p53 increased the levels of PIK3CA in SBOT3.1 cells. In contrast, overexpression of p53 decreased the levels of PIK3CA in MPSC1 cells. In correlation with the measured mRNA levels, western blot analysis showed similar results for both SBOT3.1 and MPSC1 cells (Figure 2b ). In contrast, knockdown of Rb in SBOT3.1 cells did not affect the level of PIK3CA (Figure 2c ). In addition, the levels of PIK3CA and p110a were increased in SBOT4-LT cells compared with SBOT4 cells (Supplementary Figure 4) . 
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As Akt is the major downstream target of PI3K, we examined the influence of p53 on the activation of Akt. siRNA-mediated knockdown of p53 in SBOT3.1 cells led to increased Akt phosphorylation in response to fetal bovine serum (FBS). In contrast, overexpression of p53 diminished FBS-induced Akt phosphorylation in MPSC1 cells (Figure 3a) . To further confirm the effects of PI3K/Akt on cell invasion, SBOT3.1 cells were treated with the PI3K inhibitor LY294002. As shown in Figure 3b , LY294002 inhibited basal levels of cell invasion. Interestingly, LY294002 also inhibited p53 knockdown-induced cell invasion. The involvement of PI3K in the inhibition of p53-induced cell invasion was confirmed by using another PI3K inhibitor, wortmannin (Figures 3c) . In SBOT4-LT cells, transfection of SBOT4-LT cells with dominant-negative Akt (DN-Akt) significantly decreased cell invasion (Supplementary Figure 5a) . In addition, LY294002 and wortmannin inhibited cell invasion in a dosedependent manner (Supplementary Figure 5b and c) . These results indicate that inhibition of p53 increases cell invasion by upregulating the PI3K/Akt pathway. Interestingly, inhibition of Rb also enhanced invasiveness, but did not affect the levels of PIK3CA suggesting that it may function by a different pathway.
Inhibition of p53 downregulates E-cadherin
To characterize the role of p53 in the regulation of EMT, we analyzed the levels of E-cadherin in SBOT3.1 and MPSC1 cells. As shown in Figures 4a and b , siRNA-mediated knockdown of p53 decreased the levels of E-cadherin mRNA and protein in SBOT3.1 cells. Conversely, overexpression of p53 increased the levels of E-cadherin mRNA and protein in MPSC1 cells. Immunostaining showed that manipulation of p53 did not significantly change the localization of E-cadherin in either SBOT3.1 or MPSC1 cells (Figure 4c ). In contrast, siRNA-mediated knockdown of p53 increased the expression of the mesenchymal marker N-cadherin in SBOT3.1 cells and N-cadherin was decreased in p53-overexpressing MPSC1 cells (Supplementary Figure 6) . However, siRNA-mediated knockdown of Rb did not affect the mRNA level of E-cadherin (Supplementary Figure 7) . To elucidate the mechanism responsible for the transcriptional regulation of E-cadherin, we examined the expression of Snail, Slug, Twist and ZEB1, which repress E-cadherin transcription. Knockdown of p53 increased the mRNA levels of Slug and Twist in SBOT3.1 cells. Conversely, overexpression of p53 decreased the mRNA levels of Slug and Twist in MPSC1 cells (Figure 4d ). In correlation with the measured mRNA levels, western blot analysis showed similar results for both SBOT3.1 and MPSC1 cells (Figure 4e ). However, manipulation of p53 expression did not change the levels of Snail and ZEB1 in either SBOT3.1 or MPSC1 cells (Figures 4d and e) . To confirm whether the p53 knockdown-mediated downregulation of E-cadherin was mediated by Slug and Twist, we examined the levels of E-cadherin protein in SBOT3.1 cells transfected with p53 siRNA in combination with Slug or Twist siRNA. The results showed that siRNAmediated knockdown of Slug or Twist abolishes the downregulation of E-cadherin induced by knockdown of p53. These results confirmed that Slug and/or Twist regulate p53-mediated expression of E-cadherin in SBOT cells (Figure 4f) . Consistent with the results obtained in SBOT3.1 cells, the levels of E-cadherin mRNA and protein decreased while those of Slug and Twist increased in SBOT4-LT cells compared with SBOT4 cells. In addition, the levels of N-cadherin mRNA and protein increased in SBOT4-LT cells compared with SBOT4 cells. Similarly, the levels of Snail remained unaltered in SBOT4 and SBOT4-LT cells (Supplementary Figure 8) .
Activation of the PI3K/Akt pathway is involved in the inhibition of p53-downregulated E-cadherin SBOT3.1 cells were treated with p53 siRNA and LY294002. As shown in Figure 5a , downregulation of E-cadherin caused by siRNA-mediated knockdown of p53 was abolished by treatment of the cells with LY294002. In addition, LY294002 diminished the increase of Slug and Twist caused by siRNA-mediated knockdown of p53. To further confirm the role of Akt in downregulating E-cadherin, MPSC1 cells were transfected with DN-Akt. Western blot analysis showed that DN-Akt decreased the levels of E-cadherin and increased the levels of Slug and Twist in MPSC1 cells (Figure 5b) . Furthermore, invasion assays showed that DN-Akt significantly decreased cell invasion of MPSC1cells (Figure 5c ).
E-cadherin represses invasion in SBOT and MPSC1 cells
To further examine the role of E-cadherin in the progression from non-invasive SBOT to invasive LGC, we knocked down endogenous E-cadherin in SBOT3.1 cells. siRNA-mediated knockdown of E-cadherin resulted in a decrease in E-cadherin protein levels and increased the cell invasion of SBOT3.1 cells (Figure 6a ). To further test our hypothesis that E-cadherin represses cell invasion, we decided to reverse the loss of E-cadherin by overexpressing E-cadherin. However, as 
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we observed significant effects of p53 on endogenous E-cadherin, we overexpressed E-cadherin by using an E-cadherin construct lacking regulatory elements. As shown in Figure 6b , overexpression of E-cadherin abolished the increased cell invasion of SBOT3.1 cells induced by knockdown of p53. In MPSC1 cells, overexpression of E-cadherin decreased cell invasion (Figure 6c) . In SBOT4-LT cells, overexpression of E-cadherin showed the similar results in cell invasion (Supplementary Figure 9) . These results indicated that E-cadherin has an important role in the p53-regulated cell invasion in SBOT and MPSC1 cells.
Discussion
Non-invasive SBOT and invasive LGC are thought to represent different stages in a tumorigenic continuum, and to develop along pathways distinct from invasive HGC (Bonome et al., 2005) . In this study, we attempted to discriminate between the effects of p53 and Rb on the neoplastic progression of SBOT cells by selectively inhibiting the corresponding genes. We demonstrated that inhibition of p53 or Rb alone significantly increased the invasion of SBOT cells. Inhibition of p53-induced cell invasion was mediated by activation of the PI3K/ Akt pathway and by the downregulation of E-cadherin. In contrast, inhibition of Rb did not affect the level of PIK3CA and E-cadherin. These results not only indicate that the progression from SBOT to invasive LGC involves the attenuation of p53 and Rb signaling, but also point to an unexpected function of p53 in SBOT cells, which is to suppress EMT and the transition to invasive ovarian carcinomas.
Mutation of p53 is the most common genetic alteration in invasive HGC, but it is rare in borderline tumors and invasive LGC (Schuijer and Berns, 2003; Singer et al., 2005) . Our sequence results confirmed that SBOT cells harbor wild-type p53. Recently, a microarray study showed that compared with normal ovarian surface epithelium, SBOTs are characterized by increased p53 expression levels. In addition, the level of p53 reverts back to normal when SBOTs progress to invasive LGC, suggesting that the return of p53 to levels expressed in the ovarian surface epithelium may be related to the progression of these non-invasive tumors to more aggressive invasive LGCs (Bonome et al., 2005) . In this study, we showed that SV40 LT or p53 siRNAmediated inhibition of p53 activity increases the cell invasion of SBOT cells, whereas increasing the activity of p53 in invasive LGC had the opposite effect. These results indicate that progression from non-invasive SBOT to invasive LGC involves the attenuation of p53 signaling.
Although p53 has been extensively studied for its role in the control of cell cycle checkpoints and apoptosis, recent studies suggest that it is responsible for other cellular functions, including cell adhesion, inhibition of angiogenesis, cell migration, cell fate and cytoskeleton organization (Zhao et al., 2000) . We previously showed that SBOT cells express MMP2, MMP9 and variable levels of active uPA, and that the SV40 LT/small T antigens-induced invasion in SBOT cells is not associated with changes in protease secretion . Thus, inhibiting p53 seems to increase cell motility but does not modulate protease activity.
Loss of Rb function is also a crucial event in tumorigenesis. A recent study showed that in breast cancer cells depletion of Rb downregulates E-cadherin expression and induces Cdc42-mediated actin cytoskeleton reorganization and cell invasion. In addition, during EMT, Rb and p53 expression levels are both significantly downregulated. Their results suggest that loss of Rb downregulates the expression level of E-cadherin, whereas in cells with disrupted cell-cell interactions, loss of p53 can increase cell survival and may also facilitate cell motility (Arima et al., 2008) . In this study, knockdown of Rb alone increased the invasion of SBOT3.1 cells. However, inhibition of Rb did not affect the levels of PIK3CA and E-cadherin. This would suggest the presence of additional, E-cadherinindependent, mechanisms for inhibition of Rb-induced cell invasion in SBOT cells.
The PI3K/Akt pathway is important in ovarian carcinogenesis and is implicated in the regulation of cell migration, invasion and EMT (Fresno Vara et al., 2004; Larue and Bellacosa, 2005) . Interestingly, increases in PI3K mRNA and protein levels are more frequent than increases in gene-copy number, suggesting that copy number-independent mechanisms also regulate the levels of PI3K expression in ovarian cancer cells. In this study, our sequence results show that no PIK3CA mutations were detected in SBOT cells. In addition, a recent study showed that p110a expression and Akt activation are negatively controlled by p53 (Astanehe et al., 2008) . In this study, we demonstrate that p53 also suppresses p110a expression and Akt activation in SBOT cells and that inhibition of p53-induced SBOT cell invasion was abolished when the cells were treated with the PI3K inhibitors LY294002 and wortmannin, or when transfected with DN-Akt. Taken together, these results indicate that p53-mediated suppression of PI3K/Akt signaling may be a critical factor that regulates the progression of SBOT to the invasive phenotype.
The defining characteristic of EMT is a downregulation in E-cadherin levels and concurrent upregulation of N-cadherin (Lee et al., 2006) . In this study, inhibition of p53 induced a switch from E-cadherin to N-cadherin expression. However, our previous study showed that overexpression of N-cadherin does not induce cell invasion in SBOT cells . Several studies have demonstrated that re-establishing the expression of E-cadherin in epithelial tumor cells results in a reversion from an invasive to a non-invasive phenotype (Vleminckx et al., 1991; Birchmeier and Behrens, 1994) . It has been shown that loss of E-cadherin and p53 accelerates the development of metastatic mammary carcinomas in mice (Derksen et al., 2006) . In this study, we showed that knockdown of E-cadherin induced invasiveness of SBOT3.1 cells, whereas overexpression of E-cadherin decreased MPSC1 cell invasion. Moreover, SBOT cell invasion, induced by inhibition of p53, was abolished by overexpression of E-cadherin. Thus, our results demonstrate, for the first time, that E-cadherin suppresses the invasion of SBOT cells and that it has a role in the progression from non-invasive SBOT cells to invasive tumors.
Recently, a study showed that loss of transcriptional activity of p53 downregulates E-cadherin expression by upregulation of Slug and ZEB1 in colon carcinoma cells. Their results suggest that inactivation of p53 not only contributes to cellular growth, but also permits tumor progression towards an invasive phenotype (Roger et al., 2010) . In this study, we demonstrated that p53 increases E-cadherin expression by repressing the expression of Slug and Twist, but not Snail and ZEB1. It has been shown that wild-type p53 can suppress cancer cell invasion by inducing MDM2-mediated Slug degradation, but p53 does not influence the expression of Slug mRNA. In addition, mutations in p53 correlate with low expression of MDM2, high expression of Slug and low E-cadherin levels in non-small cell lung cancer (Wang et al., 2009) . Taken together, these results suggest that p53 may regulate Slug and Twist at the transcriptional and post-translational levels. However, the detailed mechanism of this regulation requires further investigation.
In summary, our study demonstrates that inhibition of p53 induces cell invasion by upregulating the PI3K/ Akt pathway and downregulating the expression of E-cadherin in SBOT cells. These results suggest that p53, which is characteristically overexpressed in SBOT (Bonome et al., 2005) , functions as an ovarian epithelial tumor suppressor by inhibiting the progression of SBOT to invasive ovarian carcinomas.
Materials and methods

Cell culture
Institutional approval for experimentation with human tissues, including informed consent from each subject, was obtained before conducting this study. SBOT cells were cultured in a 1:1 (v/v) mixture of M199/MCDB105 medium (Sigma-Aldrich, Oakville, ON, Canada) supplemented with 10% FBS (Hyclone Laboratories Inc., Logan, UT, USA). The MPSC1 cell line, which was established from an LGC (provided by Dr Ie-Ming Shih, Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, MD, USA), was maintained in RPMI 1640 (Invitrogen, Burlington, ON, Canada) supplemented with 10% FBS (Pohl et al., 2005) .
Retrovirus production and infection Amphotropic retroviruses were produced by transfecting Phoenix retroviral packaging cells (provided by Dr R Keith Humphries, Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, Canada) with either pBABE-neobased vectors (Addgene, Cambridge, MA, USA) encoding IRES-EGFP, the SV40 LT antigen, LT K1 (has an alteration in the Rb consensus binding motif) and LT delta 434-444 (has a deletion in part of the bipartite p53 binding domain) or pBABE-zeo vectors encoding the SV40 small T antigens. All transfections were performed using Lipofectamine 2000 (Invitrogen). After transfection, the cells were purified by selection with 200 mg/ml G418 and 500 mg/ml zeomycin (Hahn et al., 2002) . The established SBOT4-LT cells were maintained in medium supplemented with 100 mg/ml G418.
siRNA transfection and protein overexpression For the inactivation of p53, Rb, Slug and Twist, cells were transfected with ON-TARGETplus SMARTpool p53 (50 nM), Rb (50 nM), Slug (100 nM) and/or Twist (100 nM) siRNA (Dharmacon Research, Inc., Lafayette, CO, USA) using Lipofectamine RNAiMAX (Invitrogen). The siCONTROL NON-TARGETINGpool siRNA (Dharmacon) was used as the transfection control. For protein overexpression, a pIRES vector encoding the full-length wild-type mouse E-cadherin (provided by Dr Carl Y Sasaki, National Institute on Aging, Baltimore, MD, USA), the pCMV-Neo-Bam-p53 vector (Addgene) and/or Myc-tagged DN-Akt (Upstate, Billerica, MA, USA) were transfected into cells using Lipofectamine 2000.
Immunofluorescence staining
Cells were cultured on coverslips, fixed in methanol at À20 1C for 20 min, post-fixed in cold methanol/acetone 1:1 for 5 min and dried. Following rehydration in phosphate-buffered saline, the coverslips were blocked with Dako Protein Block (Dako, Mississauga, ON, Canada) for 1 h and incubated with antibodies to E-cadherin, p53, SV40 T antigen (Calbiochem, San Diego, CA, USA) or keratin (rabbit anti-keratin, widespectrum screening; Dako), diluted in Dako Protein Block. Alexa 594-labeled goat anti-mouse or Alexa 488-labeled goat anti-rabbit IgG was used as a secondary antibody. Cells were counterstained with Hoechst 33258, rinsed with phosphatebuffered saline, mounted with Gelvatol, and examined using a Zeiss Axiophot epifluorescent microscope equipped with a digital camera (Q Imaging, Burnaby, BC, Canada).
Invasion assay
The invasion assay was performed in Boyden chambers as described previously (Woo et al., 2007) . Filters were coated with 1 mg/ml growth-factor reduced Matrigel (BD Biosciences, Mississauga, ON, Canada). Cells were placed in M199/ MCDB105 medium supplemented with 0.1% FBS incubated for 48 h against a gradient of 10% FBS. Cells that penetrated the membrane were fixed with cold methanol, stained with Hoechst 33258, and the number of nuclei stained with Hoechst 33258 was counted using Northern Eclipse 6.0 software from Empix Imaging (Mississauga, ON, Canada). Each individual experiment had triplicate inserts and five microscopic fields were counted per insert.
Western blots
The cells were lysed, and the protein concentrations were determined using a protein assay kit with bovine serum albumin standards according to the manufacturer's instructions (Bio-Rad Laboratories, Hercules, CA, USA). Equal amounts of cell lysates were separated by sodium dodecyl sulfate-PAGE and transferred to polyvinylidene difluoride membranes. After blocking with Tris-buffered saline containing 5% non-fat dry milk, the membranes were incubated overnight at 4 1C with anti-p110a, anti-Rb, anti-phosphoAkt Ser473 anti-Akt (all from Cell Signaling, Danvers, MA, USA), anti-E-cadherin, anti-N-cadherin (both from BD Biosciences), anti-Twist, anti-p53 (both from Santa Cruz, Santa Cruz, CA, USA), anti-Snail and anti-Slug (both from Abgent, San Diego, CA, USA) antibodies. Thereafter, the membranes were incubated with horseradish peroxidaseconjugated secondary antibody. Immunoreactive bands were detected using the enhanced chemiluminescence kit.
Reverse transcription quantitative real-time PCR (RT-qPCR) Total RNA was isolated using the RNeasy Plus kit (Qiagen, Mississauga, ON, Canada) according to the manufacturer's instructions. The RNA was reverse transcribed into firststrand complementry DNA (Amersham Pharmacia Biotech, Oakville, ON, Canada) following the manufacturer's instructions. The primers used for SYBR Green reverse transcription quantitative-PCR (RT-qPCR) were listed in Supplementary Table 1. RT-qPCR was performed on an Applied Biosystems 7300 Real-Time PCR System (Perkin-Elmer, Wellesley, MA, USA) equipped with a 96-well optical reaction plate. All RTqPCR experiments were run in triplicate and a mean value was used for the determination of mRNA levels. Relative quantification of the mRNA levels was performed using the comparative Ct method with GAPDH as the reference gene and with the formula 2 ÀDDCt .
Statistical analysis
The results are presented as the mean ± s.e.m. of at least three independent experiments. The statistical analyses were conducted using a standard t-test for paired data. Multiple comparisons were first analyzed by one-way ANOVA, followed by Tukey's multiple comparison test. P-values of o0.05 were considered statistically significant.
